Contact
Maxime Degbomont
Email
+32 (0)471 50 59 12
Vesale Bioscience, a Vesale Pharma spin-out, is dedicated to organizing the development, production and distribution of bacteriophages. Modern phage therapy is the most promising treatment against antiobiotic multiresistant bacterial (AMR) infections, one of the biggest global health challenges, referred to as “the next pandemic” by the WHO. AMR is expected to become the single largest death cause within the next quarter century, surpassing cancer.
Vesale Bioscience has developed "Inteliphage", a revolutionary automatic phagogram, IVD for a fast screening of phages. This equipment provides a diagnosis in three hours instead of the usual three days, allowing Vésale to recommend and deliver a personalized and highly effective treatment in record time, which is life-saving in many critical circumstances. In 2021, Vesale Bioscience received the BioFIT award for the most innovative life sciences start-up in Europe.
Vesale Bioscience has a close Research and Development collaboration in phage therapy with The Belgian Defense (Queen Astrid Military Hospital) and other major European Institutions. Find more information on https://phage.health
To strengthen Vesale Bioscience’s team, we are looking for a (m/f): Production Development Manager.
As a Production Development Manager, you manage the development, organization, and optimization of the bacteriophages' production. You work together with a team of Phage Specialists from Vesale Bioscience and from the Queen Astrid Military Hospital (QAMH: Lab MCT), and you ensure the connection between the two production sites. You regularly report the evolution of the project to the CSO.
Your key responsibilities and main challenges are:
Your application and related information will remain strictly confidential.